资讯

Conjunctivitis Treatment Market to Reach USD 6.24 Billion by 2032, Driven by Rising ...
U.S. Conjunctivitis Treatment Market to Hit USD 2.14 Billion by 2032 Amid Increased OTC Drug Adoption, Allergy Incidences, and Telehealth Growth.Austin, July 15, 2025 (GLOBE NEWSWIRE) -- ...
Business Opportunities In The $838 Million Vernal Keratoconjunctivitis Market 2025-2034 ...
Key drivers include increasing adult cases and a shift towards immunomodulatory therapies like Cyclosporine A. Expansion in allergy clinics and strat ...